Search filters

List of works by David F L Liew

A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding

scholarly article by Christopher McMaster et al published 1 June 2019 in Drug Safety

Association of good oncological response to therapy with the development of rheumatic immune-related adverse events following PD-1 inhibitor therapy

scientific article published on 22 November 2018

Better pharmacovigilance through artificial intelligence: What is needed to make this a reality?

scientific article published on 27 April 2022

COVID-19: collaboration will keep us ahead of the curve

scientific article published on 01 July 2020

Fatal azathioprine toxicity

scientific article published on June 2017

Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica

scientific article published on 7 November 2017

Letter to the editor: Comments on 'A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica'

scientific article published on 28 February 2019

Medicines stewardship

scientific article published in 2023

Musculotendinous Inflammation: The Defining Pathology of Polymyalgia Rheumatica?

scientific article published on 01 December 2019

Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumatica

scientific article published on 12 October 2020

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

scientific article published in December 2021

Palliative and Supportive Care Prescribing Considerations Around QT Prolongation Risk in the Context of COVID-19 (Coronavirus Disease 2019) Management

scientific article published on 22 September 2020

Prescribing for polymyalgia rheumatica.

scientific article published in February 2018

Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

scientific article published on 13 November 2018

Waiting for JAK inhibitor safety data

scientific article published in 2022